Tuesday, March 11, 2025 | 11:26 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sun Pharma launches cheapest favipiravir brand in India, at Rs 35 a pill

Pricing pressure in this category is already visible as Glenmark revised its original price (Rs 103 per tablet) to Rs 79 per tablet within a month of the launch

Favipiravir, Umifenovir, atniviral, drugs, pharma, coronavirus, covid-19, sars, cov-2
Premium

Favipiravir is used for the treatment of mild to moderate cases of Covid-19 in India

Sohini Das Mumbai
Joining the long list of firms to launch its own brand of oral antiviral drug favipiravir, the country's largest drugmaker Sun Pharmaceutical Industries on Tuesday launched the cheapest brand of favipiravir in the market - FluGuard. 

Priced at Rs 35 a tablet this will be the cheapest brand available so far. Jenburkt Pharma's brand Favivent is priced at Rs 39 per tablet. 

Favipiravir is used for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

Kirti Ganorkar,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in